A novel ATM-dependent checkpoint defect distinct from loss of function mutation promotes genomic instability in...

Area of Science:

• Oncology
• Genetics
• Cell Biology

Background:

• Melanomas exhibit significant genomic instability, correlating with poor prognosis.
• The ATM-dependent cell cycle checkpoint is crucial for maintaining genomic integrity following DNA damage.

Purpose of the Study:

• To identify novel defects in the ATM-dependent cell cycle checkpoint in melanoma.
• To investigate the role of Polo-like kinase 1 (PLK1) in this checkpoint defect and its contribution to genomic instability.

Main Methods:

• Analysis of ATM signaling, CHK2 activation, and cell cycle arrest in melanoma cell lines.
• Manipulation of PLK1 activity (reduction and overexpression) to assess its impact on checkpoint function.
• Assessment of genomic instability and sensitivity to ionizing radiation.

Main Results:

• Melanoma cell lines with defects in the ATM-dependent checkpoint show intact ATM-CHK2 signaling but fail to maintain cell cycle arrest.
• Elevated PLK1 activity drives premature recovery from the ATM-dependent arrest, leading to increased genomic instability.
• Reducing PLK1 restored checkpoint arrest, while PLK1 overexpression bypassed the arrest and heightened instability.
• This checkpoint defect is distinct from ATM loss-of-function mutations and is associated with high PLK1 levels in a subset of melanomas.

Conclusions:

• A novel ATM-dependent cell cycle checkpoint defect, driven by elevated PLK1, promotes genomic instability in melanoma.
• This defect appears to be a common feature in melanomas and may be present in other cancers.
• Targeting PLK1 could be a therapeutic strategy for melanomas with this specific checkpoint deficiency.